Bank of New Hampshire Sells 647 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Bank of New Hampshire trimmed its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 41.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 923 shares of the exchange traded fund’s stock after selling 647 shares during the period. Bank of New Hampshire’s holdings in SPDR S&P Biotech ETF were worth $82,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Phoenix Holdings Ltd. raised its holdings in shares of SPDR S&P Biotech ETF by 0.8% during the third quarter. Phoenix Holdings Ltd. now owns 2,151,359 shares of the exchange traded fund’s stock worth $157,092,000 after acquiring an additional 17,221 shares during the period. Healthcare of Ontario Pension Plan Trust Fund increased its stake in SPDR S&P Biotech ETF by 103.3% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,771,000 shares of the exchange traded fund’s stock valued at $129,318,000 after buying an additional 900,000 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. acquired a new stake in SPDR S&P Biotech ETF in the 3rd quarter valued at $102,900,000. Bank Julius Baer & Co. Ltd Zurich increased its stake in SPDR S&P Biotech ETF by 4.4% in the 3rd quarter. Bank Julius Baer & Co. Ltd Zurich now owns 627,917 shares of the exchange traded fund’s stock valued at $45,850,000 after buying an additional 26,728 shares during the last quarter. Finally, MBB Public Markets I LLC increased its stake in SPDR S&P Biotech ETF by 67.0% in the 3rd quarter. MBB Public Markets I LLC now owns 514,411 shares of the exchange traded fund’s stock valued at $37,562,000 after buying an additional 206,337 shares during the last quarter.

SPDR S&P Biotech ETF Trading Down 2.0 %

Shares of XBI traded down $1.72 during midday trading on Thursday, reaching $82.22. The stock had a trading volume of 14,307,263 shares, compared to its average volume of 11,733,762. The firm has a 50 day simple moving average of $93.10 and a 200-day simple moving average of $84.57. SPDR S&P Biotech ETF has a one year low of $63.80 and a one year high of $103.52. The firm has a market cap of $6.39 billion, a PE ratio of 11.47 and a beta of 1.08.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.